iBio (Early-Stage Cell Death Protein 1 Agonist Program in Bryan, Texas) Overview
- Status
-
Acquired/Merged
- Latest Deal Type
-
Asset Purch.
- Financing Rounds
-
1
iBio (Early-Stage Cell Death Protein 1 Agonist Program in Bryan, Texas) General Information
Description
Early-Stage Cell Death Protein 1 Agonist Program is based in Bryan, Texas.
Contact Information
Corporate Office
- Bryan, TX
- United States
Corporate Office
- Bryan, TX
- United States
iBio (Early-Stage Cell Death Protein 1 Agonist Program in Bryan, Texas) Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
iBio (Early-Stage Cell Death Protein 1 Agonist Program in Bryan, Texas) Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
iBio (Early-Stage Cell Death Protein 1 Agonist Program in Bryan, Texas) FAQs
-
Where is iBio (Early-Stage Cell Death Protein 1 Agonist Program in Bryan, Texas) headquartered?
iBio (Early-Stage Cell Death Protein 1 Agonist Program in Bryan, Texas) is headquartered in Bryan, TX.
-
What industry is iBio (Early-Stage Cell Death Protein 1 Agonist Program in Bryan, Texas) in?
iBio (Early-Stage Cell Death Protein 1 Agonist Program in Bryan, Texas)’s primary industry is Buildings and Property.
-
Is iBio (Early-Stage Cell Death Protein 1 Agonist Program in Bryan, Texas) a private or public company?
iBio (Early-Stage Cell Death Protein 1 Agonist Program in Bryan, Texas) is a Private company.
-
What is the current valuation of iBio (Early-Stage Cell Death Protein 1 Agonist Program in Bryan, Texas)?
The current valuation of iBio (Early-Stage Cell Death Protein 1 Agonist Program in Bryan, Texas) is .
-
What is iBio (Early-Stage Cell Death Protein 1 Agonist Program in Bryan, Texas)’s current revenue?
The current revenue for iBio (Early-Stage Cell Death Protein 1 Agonist Program in Bryan, Texas) is .
-
Who are iBio (Early-Stage Cell Death Protein 1 Agonist Program in Bryan, Texas)’s investors?
iBio has invested in iBio (Early-Stage Cell Death Protein 1 Agonist Program in Bryan, Texas).
-
When was iBio (Early-Stage Cell Death Protein 1 Agonist Program in Bryan, Texas) acquired?
iBio (Early-Stage Cell Death Protein 1 Agonist Program in Bryan, Texas) was acquired on 25-Feb-2024.
-
Who acquired iBio (Early-Stage Cell Death Protein 1 Agonist Program in Bryan, Texas)?
iBio (Early-Stage Cell Death Protein 1 Agonist Program in Bryan, Texas) was acquired by Otsuka Pharmaceutical.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process